IRONWOOD PHARMACEUTICALS, INC. Selling, General and Administrative Expense
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Selling, General and Administrative Expense of $11.31 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-06
- IRONWOOD PHARMACEUTICALS, INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $11.31M, a 32.64% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $12.03M, a 50.40% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. selling, general and administrative expense for the quarter ending 2025-12-31 was $19.29M, a 42.56% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $21.91M, a 39.33% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. selling, general and administrative expense for fiscal 2025 was $82.26M, a 42.99% decline from fiscal 2024.
- IRONWOOD PHARMACEUTICALS, INC. selling, general and administrative expense for fiscal 2024 was $144.27M, a 8.87% decline from fiscal 2023.
- IRONWOOD PHARMACEUTICALS, INC. selling, general and administrative expense for fiscal 2023 was $158.31M, a 36.48% increase from fiscal 2022.
- IRONWOOD PHARMACEUTICALS, INC. selling, general and administrative expense for fiscal 2022 was $115.99M, a 4.37% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $11.31M 10-Q · filed 2026-08-06 | $23.35M 10-Q · filed 2026-08-06 | $42.64M derived: sum of 3 quarters · filed 2026-08-06 | $64.55M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $12.03M 10-Q · filed 2026-05-07 | $31.33M derived: sum of 2 quarters · filed 2026-05-07 | $53.23M derived: sum of 3 quarters · filed 2026-05-07 | $70.03M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $19.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $41.20M derived: sum of 2 quarters · filed 2026-02-26 | $58.00M derived: sum of 3 quarters · filed 2026-08-06 | $82.26M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $21.91M 10-Q · filed 2025-11-10 | $38.70M derived: sum of 2 quarters · filed 2026-08-06 | $62.96M 10-Q · filed 2025-11-10 | $96.55M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $16.80M 10-Q · filed 2026-08-06 | $41.05M 10-Q · filed 2026-08-06 | $74.64M derived: sum of 3 quarters · filed 2026-08-06 | $110.76M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $24.26M 10-Q · filed 2026-05-07 | $57.85M derived: sum of 2 quarters · filed 2026-05-07 | $93.96M derived: sum of 3 quarters · filed 2026-05-07 | $130.93M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $33.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $69.70M derived: sum of 2 quarters · filed 2026-02-26 | $106.67M derived: sum of 3 quarters · filed 2026-02-26 | $144.27M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $36.11M 10-Q · filed 2025-11-10 | $73.08M derived: sum of 2 quarters · filed 2025-11-10 | $110.68M 10-Q · filed 2025-11-10 | $149.35M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | $36.96M 10-Q · filed 2025-08-11 | $74.57M 10-Q · filed 2025-08-11 | $113.24M derived: sum of 3 quarters · filed 2025-08-11 | $149.28M derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | $37.60M 10-Q · filed 2025-05-12 | $76.27M derived: sum of 2 quarters · filed 2025-05-12 | $112.32M derived: sum of 3 quarters · filed 2025-05-12 | $164.80M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $38.67M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $74.71M derived: sum of 2 quarters · filed 2025-03-31 | $127.20M derived: sum of 3 quarters · filed 2025-03-31 | $158.31M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $36.05M 10-Q · filed 2024-11-07 | $88.53M derived: sum of 2 quarters · filed 2024-11-07 | $119.65M 10-Q · filed 2024-11-07 | $148.04M derived: sum of 4 quarters · filed 2025-03-31 | ||||
| 2023-06-30 | $52.48M 10-Q · filed 2024-08-08 | $83.60M 10-Q · filed 2024-08-08 | $111.99M derived: sum of 3 quarters · filed 2025-03-31 | $140.61M derived: sum of 4 quarters · filed 2025-03-31 | ||||
| 2023-03-31 | $31.12M 10-Q · filed 2024-05-09 | $59.51M derived: sum of 2 quarters · filed 2025-03-31 | $88.13M derived: sum of 3 quarters · filed 2025-03-31 | $118.25M derived: sum of 4 quarters · filed 2025-03-31 | ||||
| 2022-12-31 | $28.39M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $57.01M derived: sum of 2 quarters · filed 2025-03-31 | $87.13M derived: sum of 3 quarters · filed 2025-03-31 | $115.99M 10-K · filed 2025-03-31 | ||||
| 2022-09-30 | $28.62M 10-Q · filed 2023-11-09 | $58.74M derived: sum of 2 quarters · filed 2023-11-09 | $87.60M 10-Q · filed 2023-11-09 | $116.29M derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2022-06-30 | $30.12M 10-Q · filed 2023-08-09 | $58.98M 10-Q · filed 2023-08-09 | $87.67M derived: sum of 3 quarters · filed 2024-02-16 | $115.41M derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2022-03-31 | $28.86M 10-Q · filed 2023-05-04 | $57.55M derived: sum of 2 quarters · filed 2024-02-16 | $85.29M derived: sum of 3 quarters · filed 2024-02-16 | $112.34M derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2021-12-31 | $28.69M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $56.43M derived: sum of 2 quarters · filed 2024-02-16 | $83.48M derived: sum of 3 quarters · filed 2024-02-16 | $111.13M 10-K · filed 2024-02-16 | ||||
| 2021-09-30 | $27.74M 10-Q · filed 2022-11-03 | $54.79M derived: sum of 2 quarters · filed 2022-11-03 | $82.45M 10-Q · filed 2022-11-03 | $116.43M derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-06-30 | $27.05M 10-Q · filed 2022-08-04 | $54.70M 10-Q · filed 2022-08-04 | $88.69M derived: sum of 3 quarters · filed 2023-02-16 | $123.61M derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-03-31 | $27.65M 10-Q · filed 2022-05-05 | $61.63M derived: sum of 2 quarters · filed 2023-02-16 | $96.56M derived: sum of 3 quarters · filed 2023-02-16 | $131.21M derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2020-12-31 | $33.98M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $68.91M derived: sum of 2 quarters · filed 2023-02-16 | $103.55M derived: sum of 3 quarters · filed 2023-02-16 | $140.00M 10-K · filed 2023-02-16 | ||||
| 2020-09-30 | $34.93M 10-Q · filed 2021-11-04 | $69.57M derived: sum of 2 quarters · filed 2021-11-04 | $106.02M 10-Q · filed 2021-11-04 | $145.21M derived: sum of 4 quarters · filed 2022-02-18 | ||||
| 2020-06-30 | $34.64M 10-Q · filed 2021-08-05 | $71.09M 10-Q · filed 2021-08-05 | $110.28M derived: sum of 3 quarters · filed 2022-02-18 | $151.20M derived: sum of 4 quarters · filed 2022-02-18 | ||||
| 2020-03-31 | $36.45M 10-Q · filed 2021-05-06 | $75.64M derived: sum of 2 quarters · filed 2022-02-18 | $116.56M derived: sum of 3 quarters · filed 2022-02-18 | $159.81M derived: sum of 4 quarters · filed 2022-02-18 | ||||
| 2019-12-31 | $39.19M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $80.11M derived: sum of 2 quarters · filed 2022-02-18 | $123.36M derived: sum of 3 quarters · filed 2022-02-18 | $172.45M 10-K · filed 2022-02-18 | ||||
| 2019-09-30 | $40.92M 10-Q · filed 2020-11-05 | $84.17M derived: sum of 2 quarters · filed 2020-11-05 | $133.26M 10-Q · filed 2020-11-05 | $183.68M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2019-06-30 | $43.25M 10-Q · filed 2020-08-06 | $92.34M 10-Q · filed 2020-08-06 | $142.76M derived: sum of 3 quarters · filed 2021-02-17 | $193.30M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2019-03-31 | $49.09M 10-Q · filed 2020-05-06 | $64.74M 10-Q · filed 2019-05-02 | $99.52M derived: sum of 2 quarters · filed 2021-02-17 | $150.06M derived: sum of 3 quarters · filed 2021-02-17 | $209.83M derived: sum of 4 quarters · filed 2021-02-17 | |||
| 2018-12-31 | $50.42M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $100.96M derived: sum of 2 quarters · filed 2021-02-17 | $160.73M derived: sum of 3 quarters · filed 2021-02-17 | $219.68M 10-K · filed 2021-02-17 | $241.29M 10-K · filed 2019-02-25 | |||
| 2018-09-30 | $50.54M 10-Q · filed 2019-10-31 | $55.25M 10-Q · filed 2018-11-06 | $110.31M derived: sum of 2 quarters · filed 2019-10-31 | $169.25M 10-Q · filed 2019-10-31 | $183.11M 10-Q · filed 2018-11-06 | $225.82M derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2018-06-30 | $59.77M 10-Q · filed 2019-07-30 | $68.36M 10-Q · filed 2018-08-06 | $118.72M 10-Q · filed 2019-07-30 | $127.86M 10-Q · filed 2018-08-06 | $175.29M derived: sum of 3 quarters · filed 2020-02-13 | $237.06M derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2018-03-31 | $59.50M 10-Q · filed 2019-05-02 | $61.92M 10-Q · filed 2018-05-04 | $115.52M derived: sum of 2 quarters · filed 2020-02-13 | $177.29M derived: sum of 3 quarters · filed 2020-02-13 | $235.08M derived: sum of 4 quarters · filed 2020-02-13 | |||
| 2017-12-31 | $56.01M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $117.79M derived: sum of 2 quarters · filed 2020-02-13 | $175.58M derived: sum of 3 quarters · filed 2020-02-13 | $231.18M 10-K · filed 2020-02-13 | $233.12M 10-K · filed 2018-02-22 | |||
| 2017-09-30 | $61.77M 10-Q · filed 2018-11-06 | $119.57M derived: sum of 2 quarters · filed 2018-11-06 | $175.17M 10-Q · filed 2018-11-06 | $230.38M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-06-30 | $57.79M 10-Q · filed 2018-08-06 | $113.40M 10-Q · filed 2018-08-06 | $168.60M derived: sum of 3 quarters · filed 2019-02-25 | $213.59M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-03-31 | $55.60M 10-Q · filed 2018-05-04 | $110.81M derived: sum of 2 quarters · filed 2019-02-25 | $155.80M derived: sum of 3 quarters · filed 2019-02-25 | $192.72M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2016-12-31 | $55.21M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $100.19M derived: sum of 2 quarters · filed 2019-02-25 | $137.11M derived: sum of 3 quarters · filed 2019-02-25 | $173.28M 10-K · filed 2019-02-25 | ||||
| 2016-09-30 | $44.99M 10-Q · filed 2017-11-02 | $81.91M derived: sum of 2 quarters · filed 2017-11-02 | $118.07M 10-Q · filed 2017-11-02 | $149.58M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-06-30 | $36.92M 10-Q · filed 2017-08-03 | $73.09M 10-Q · filed 2017-08-03 | $104.59M derived: sum of 3 quarters · filed 2018-02-22 | $135.03M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-03-31 | $36.17M 10-Q · filed 2017-05-08 | $67.67M derived: sum of 2 quarters · filed 2018-02-22 | $98.11M derived: sum of 3 quarters · filed 2018-02-22 | $131.07M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2015-12-31 | $31.51M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $61.95M derived: sum of 2 quarters · filed 2018-02-22 | $94.90M derived: sum of 3 quarters · filed 2018-02-22 | $125.25M 10-K · filed 2018-02-22 | ||||
| 2015-09-30 | $30.44M 10-Q · filed 2016-11-07 | $63.39M derived: sum of 2 quarters · filed 2016-11-07 | $93.74M 10-Q · filed 2016-11-07 | $124.31M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2015-06-30 | $32.95M 10-Q · filed 2016-08-08 | $63.30M 10-Q · filed 2016-08-08 | $93.88M derived: sum of 3 quarters · filed 2017-02-22 | $122.41M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2015-03-31 | $30.35M 10-Q · filed 2016-05-10 | $60.92M derived: sum of 2 quarters · filed 2017-02-22 | $89.46M derived: sum of 3 quarters · filed 2017-02-22 | $118.75M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2014-12-31 | $30.57M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $59.11M derived: sum of 2 quarters · filed 2017-02-22 | $88.41M derived: sum of 3 quarters · filed 2017-02-22 | $118.33M 10-K · filed 2017-02-22 | ||||
| 2014-09-30 | $28.54M 10-Q · filed 2015-11-05 | $57.83M derived: sum of 2 quarters · filed 2015-11-05 | $87.76M 10-Q · filed 2015-11-05 | $116.48M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-06-30 | $29.30M 10-Q · filed 2015-08-07 | $59.22M 10-Q · filed 2015-08-07 | $87.94M derived: sum of 3 quarters · filed 2016-02-19 | $118.21M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-03-31 | $29.92M 10-Q · filed 2015-05-06 | $58.64M derived: sum of 2 quarters · filed 2016-02-19 | $88.91M derived: sum of 3 quarters · filed 2016-02-19 | $119.78M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2013-12-31 | $28.72M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $58.98M derived: sum of 2 quarters · filed 2016-02-19 | $89.85M derived: sum of 3 quarters · filed 2016-02-19 | $123.23M 10-K · filed 2016-02-19 | ||||
| 2013-09-30 | $30.26M 10-Q · filed 2014-11-05 | $61.13M derived: sum of 2 quarters · filed 2014-11-05 | $94.51M 10-Q · filed 2014-11-05 | $127.78M derived: sum of 4 quarters · filed 2015-02-18 | ||||
| 2013-06-30 | $30.87M 10-Q · filed 2014-08-05 | $64.24M 10-Q · filed 2014-08-05 | $97.52M derived: sum of 3 quarters · filed 2015-02-18 | $120.36M derived: sum of 4 quarters · filed 2015-02-18 | ||||
| 2013-03-31 | $33.37M 10-Q · filed 2014-04-29 | $66.65M derived: sum of 2 quarters · filed 2015-02-18 | $89.49M derived: sum of 3 quarters · filed 2015-02-18 | $109.59M derived: sum of 4 quarters · filed 2015-02-18 | ||||
| 2012-12-31 | $33.27M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $56.12M derived: sum of 2 quarters · filed 2015-02-18 | $76.22M derived: sum of 3 quarters · filed 2015-02-18 | $92.54M 10-K · filed 2015-02-18 | ||||
| 2012-09-30 | $22.85M 10-Q · filed 2013-10-28 | $42.95M derived: sum of 2 quarters · filed 2013-10-28 | $59.26M 10-Q · filed 2013-10-28 | |||||
| 2012-06-30 | $20.10M 10-Q · filed 2013-08-08 | $36.42M 10-Q · filed 2013-08-08 | ||||||
| 2012-03-31 | $16.32M 10-Q · filed 2013-04-23 | |||||||
| 2011-12-31 | $45.92M 10-K · filed 2014-02-07 | |||||||
| 2010-12-31 | $27.17M 10-K · filed 2013-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |